Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AKZA - NL0013267909 - Common Stock

56.04 EUR
+0.44 (+0.79%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

4

AKZA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 74 industry peers in the Chemicals industry. While AKZA is still in line with the averages on profitability rating, there are concerns on its financial health. AKZA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AKZA had positive earnings in the past year.
In the past year AKZA had a positive cash flow from operations.
In the past 5 years AKZA has always been profitable.
Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

AKZA has a Return On Assets (0.42%) which is in line with its industry peers.
AKZA has a Return On Equity of 1.48%. This is comparable to the rest of the industry: AKZA outperforms 48.65% of its industry peers.
AKZA has a Return On Invested Capital (3.70%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AKZA is in line with the industry average of 6.48%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

AKZA has a Profit Margin (0.56%) which is in line with its industry peers.
In the last couple of years the Profit Margin of AKZA has declined.
Looking at the Operating Margin, with a value of 4.84%, AKZA is in line with its industry, outperforming 51.35% of the companies in the same industry.
In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
Looking at the Gross Margin, with a value of 39.78%, AKZA is in line with its industry, outperforming 55.41% of the companies in the same industry.
In the last couple of years the Gross Margin of AKZA has remained more or less at the same level.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

AKZA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AKZA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AKZA has less shares outstanding
The debt/assets ratio for AKZA has been reduced compared to a year ago.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.03 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AKZA (2.03) is worse than 60.81% of its industry peers.
AKZA has a debt to FCF ratio of 10.17. This is a negative value and a sign of low solvency as AKZA would need 10.17 years to pay back of all of its debts.
The Debt to FCF ratio of AKZA (10.17) is comparable to the rest of the industry.
AKZA has a Debt/Equity ratio of 0.93. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
AKZA's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. AKZA is outperformed by 78.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.03
ROIC/WACC0.66
WACC5.64%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

AKZA has a Current Ratio of 1.25. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
AKZA's Current ratio of 1.25 is on the low side compared to the rest of the industry. AKZA is outperformed by 78.38% of its industry peers.
A Quick Ratio of 0.92 indicates that AKZA may have some problems paying its short term obligations.
AKZA's Quick ratio of 0.92 is on the low side compared to the rest of the industry. AKZA is outperformed by 62.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for AKZA have decreased by -2.93% in the last year.
The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
The Revenue has decreased by -2.03% in the past year.
AKZA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.92% yearly.
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%

3.2 Future

The Earnings Per Share is expected to grow by 9.67% on average over the next years. This is quite good.
Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y6.92%
EPS Next 2Y8.78%
EPS Next 3Y8.67%
EPS Next 5Y9.67%
Revenue Next Year-3.22%
Revenue Next 2Y-1.67%
Revenue Next 3Y-0.19%
Revenue Next 5Y4.06%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.40, the valuation of AKZA can be described as correct.
75.68% of the companies in the same industry are more expensive than AKZA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.31, AKZA is valued a bit cheaper.
A Price/Forward Earnings ratio of 12.18 indicates a correct valuation of AKZA.
Based on the Price/Forward Earnings ratio, AKZA is valued a bit cheaper than the industry average as 74.32% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, AKZA is valued rather cheaply.
Industry RankSector Rank
PE 15.4
Fwd PE 12.18
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKZA is valued a bit more expensive than 62.16% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AKZA is valued a bit cheaper than the industry average as 75.68% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.22
EV/EBITDA 15.5
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.22
PEG (5Y)3.46
EPS Next 2Y8.78%
EPS Next 3Y8.67%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.56%, AKZA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.15, AKZA pays a bit more dividend than its industry peers.
AKZA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.56%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

AKZA pays out 691.38% of its income as dividend. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y8.78%
EPS Next 3Y8.67%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (11/28/2025, 7:00:00 PM)

56.04

+0.44 (+0.79%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-27 2026-01-27/amc
Inst Owners66.98%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.59B
Revenue(TTM)10.40B
Net Income(TTM)58.00M
Analysts77.6
Price Target70.26 (25.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.56%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)-1.6%
PT rev (3m)-0.71%
EPS NQ rev (1m)10.96%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-2.04%
EPS NY rev (3m)-2.39%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 15.4
Fwd PE 12.18
P/S 0.92
P/FCF 18.22
P/OCF 11.29
P/B 2.44
P/tB 65.66
EV/EBITDA 15.5
EPS(TTM)3.64
EY6.5%
EPS(NY)4.6
Fwd EY8.21%
FCF(TTM)3.08
FCFY5.49%
OCF(TTM)4.96
OCFY8.86%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)2.22
PEG (5Y)3.46
Graham Number43.38
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.03
F-Score5
WACC5.64%
ROIC/WACC0.66
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
EPS Next Y6.92%
EPS Next 2Y8.78%
EPS Next 3Y8.67%
EPS Next 5Y9.67%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%
Revenue Next Year-3.22%
Revenue Next 2Y-1.67%
Revenue Next 3Y-0.19%
Revenue Next 5Y4.06%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year36.41%
EBIT Next 3Y15.61%
EBIT Next 5Y9.68%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


Can you provide the valuation status for AKZO NOBEL N.V.?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


How profitable is AKZO NOBEL N.V. (AKZA.AS) stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


How financially healthy is AKZO NOBEL N.V.?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 6.92% in the next year.